發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

 _____     __   __     _____    _____      _____  
|  __ \\   \ \\/ //   / ___//  |  ___||   / ___// 
| |  \ ||   \ ` //    \___ \\  | ||__     \___ \\ 
| |__/ ||    | ||     /    //  | ||__     /    // 
|_____//     |_||    /____//   |_____||  /____//  
 -----`      `-`'   `-----`    `-----`  `-----`